LB PHARMACEUTICALS INC (LBRX) (CIK 0001691082) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-25-198852
- Form
- CORRESP
- Filer
- LB PHARMACEUTICALS INC (LBRX) (CIK 0001691082)
- CIK
- 0001691082
- Ticker
- LBRX
- Filed
- 2025-09-09
- SIC industry
- 2834
- HQ
- New York, NY
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1691082/000119312525198852/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer